Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with RapamycinKatrin Friedbichler, Paul J. Adam|Molecular Cancer Therapeutics|2013Cited by 99
Supplementary Materials and Methods, Tables 1-2 and Figure Legends from Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with RapamycinKatrin Friedbichler, Paul J. Adam|Unknown|2023Cited by 0